TY - JOUR T1 - How do World and European Standard Populations impact Burden of Disease studies? A case study of Disability-Adjusted Life Years in Scotland JF - medRxiv DO - 10.1101/19008102 SP - 19008102 AU - Grant MA Wyper AU - Ian Grant AU - Eilidh Fletcher AU - Gerry McCartney AU - Colin Fischbacher AU - Diane L Stockton Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/16/19008102.abstract N2 - Background Disability-Adjusted Life Years (DALYs) are an established method for quantifying population health needs and guiding prioritisation decisions. Global Burden of Disease (GBD) estimates aim to ensure comparability between countries and over time by using age-standardised rates (ASR) to account for differences in the age structure of different populations. Different standard populations are used for this purpose but it is not widely appreciated that the choice of standard may affect not only the resulting rates but also the rankings of causes of DALYs. We aimed to evaluate the impact of the choice of standard, using the example of Scotland.Methods DALY estimates were derived from the 2016 Scottish Burden of Disease (SBOD) study for an abridged list of 68 causes of disease/injury, representing a three-year annual average across 2014-16. Crude DALY rates were calculated using Scottish national population estimates. DALY ASRs standardised using the GBD World Standard Population (GBD WSP) were compared to those using the 2013 European Standard Population (ESP2013). Differences in ASR and in rank order within the cause list were summarised across all-causes and for each individual cause.Results The ranking of causes by DALYs were similar using crude rates or ASR (ESP2013). As expected, all-cause DALY rates using ASR (GBD WSP) were around 26% lower. Overall 58 out of 68 causes had a lower ASR using GBD WSP compared with ESP2013, with the largest falls occurring for leading causes of mortality observed in older ages. Gains in ASR were much smaller in scale and largely affected causes that operated early in life. These differences were associated with a substantial change to the ranking of causes when GBD WSP was used compared with ESP2013.Conclusion Disease rankings based on DALY ASRs are strongly influenced by the choice of standard population. While GBD WSP offers international comparability, within-country analyses based on DALY ASRs should reflect local age structures. For European countries including Scotland, ESP2013 may better guide local priority setting.Competing Interest StatementIG is a UK management committee member of the COST (https://www.cost.eu/) action CA18218 (European Burden of Disease Network). GW is a substitute management committee member for the UK. All other authors declare that they have no competing interests.Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. GW, IG, GM, CF, EF, DS are salaried by NHSScotland.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThe underlying data that support the findings of this study are available from the eDRIS team at Information Services Division, NHS National Services Scotland (email: NSS.eDRIS{at}nhs.net; Tel: 0131 275 7333; Address: Farr Institute Scotland, Nine Edinburgh Bioquarter, Little France Road, Edinburgh, EH16 4UX), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Summary data used in this study are available in the Additional files.ASRAge-standardised rateBODBurden of DiseaseDALYsDisability-Adjusted Life YearsESP20132013 European Standard PopulationGBDGlobal Burden of DiseaseGBDWSP Global Burden of Disease World Standard PopulationNORDCANCancer statistics for the Nordic countriesSBODScottish Burden of DiseaseUKUnited KingdomUSUnited StatesYLLYears of Life Lost ER -